Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cisadane Sawit Raya Tbk (CSRA) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Cisadane Sawit Raya TbkTrade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Cisadane Sawit Raya Tbk vs UBC Medical Indonesia Tbk. — how do they compare? Cisadane Sawit Raya Tbk trades at Rp740 (market cap 1.53T, 23.6K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp165 (market cap 635.95B, 843K 24h volume). The key difference: Cisadane Sawit Raya Tbk is far larger — about 2.4× UBC Medical Indonesia Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (843K versus 23.6K). Which is the better fit depends on your goals.

CSRALABS
Market Cap
1.53T635.95B
Volume
23.6K843K
Lot
2368.43K
Turnover
17.42M137.6M
Average Price
738.11163.22
Value
17.42M137.6M
Indicative Equilibrium Price
740165
Indicative Equilibrium Volume
10246

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

CSRA
View details
LABS
View details

About Cisadane Sawit Raya Tbk

PT Cisadane Sawit Raya Tbk (the Company) was established based on Notarial Deed No. 82 dated October 28, 1983 of Public Notary Erly Soehandjojo, S.H., amended by Notarial Deed No. 107 dated November 25, 1987 of Public Notary H.Z. Simon, S.H.

Read more on CSRA

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS